Parapharyngeal abscess in a patient receiving etanercept

• Published in: The Annals of pharmacotherapy Vol. 41; no. 2; p. 341
• Main Authors: Borrás-Blasco, Joaquín, Nuñez-Cornejo, Claudia, Gracia-Perez, Antonio, Rosique-Robles, J Dolores, Casterá, M D Elvira, Viosca, Enrique, Abad, F Javier
• Format: Journal Article
• Language: English
• Published: United States 01.02.2007
• Subjects: Abscess - drug therapy; Abscess - etiology; Abscess - microbiology; Adult; Anti-Bacterial Agents - therapeutic use; Anti-Inflammatory Agents, Non-Steroidal - administration & dosage; Anti-Inflammatory Agents, Non-Steroidal - adverse effects; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; Arthritis, Rheumatoid - drug therapy; Etanercept; Humans; Immunoglobulin G - administration & dosage; Immunoglobulin G - adverse effects; Immunoglobulin G - therapeutic use; Immunosuppressive Agents - administration & dosage; Immunosuppressive Agents - adverse effects; Immunosuppressive Agents - therapeutic use; Male; Pharyngeal Diseases - drug therapy; Pharyngeal Diseases - etiology; Pharyngeal Diseases - microbiology; Receptors, Tumor Necrosis Factor - administration & dosage; Receptors, Tumor Necrosis Factor - therapeutic use; Streptococcal Infections - drug therapy; Streptococcal Infections - etiology; Streptococcal Infections - microbiology; Treatment Outcome; Viridans Streptococci - drug effects; Viridans Streptococci - isolation & purification

To report a case of parapharyngeal abscess associated with Streptococcus viridans in a patient with rheumatoid arthritis receiving treatment with etanercept. A 40-year-old man diagnosed with rheumatoid arthritis had received treatment with nonsteroidal antiinflammatory drugs, methotrexate, and defla...